Quick Answer
Apyx Medical Corp reported Operating Income Loss of -$6.45 million for the year ending 2025.
- Apyx Medical Corp showed an increase of +65.8% in Operating Income Loss from 2024 to 2025.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $585.0 thousand | Q2 2011: $549.0 thousand | Q3 2011: $248.0 thousand | Q1 2012: $396.0 thousand | Q2 2012: $240.0 thousand | Q3 2012: $282.0 thousand | Q1 2013: -$665.0 thousand | Q2 2013: -$1.65 million | Q3 2013: -$475.0 thousand | Q1 2014: $58.0 thousand | Q2 2014: -$1.75 million | Q3 2014: -$2.37 million | Q1 2015: -$2.27 million | Q2 2015: -$1.55 million | Q3 2015: -$1.81 million | Q1 2016: -$1.99 million | Q2 2016: -$510.0 thousand | Q3 2016: -$245.0 thousand | Q1 2017: -$1.74 million | Q2 2017: -$1.31 million | Q3 2017: -$2.83 million | Q1 2018: -$2.72 million | Q2 2018: -$2.93 million | Q3 2018: -$2.79 million | Q1 2019: -$5.73 million | Q2 2019: -$4.42 million | Q3 2019: -$4.76 million | Q1 2020: -$7.49 million | Q2 2020: -$6.17 million | Q3 2020: -$4.37 million | Q1 2021: -$4.75 million | Q2 2021: -$4.04 million | Q3 2021: -$3.97 million | Q1 2022: -$5.87 million | Q2 2022: -$5.98 million | Q3 2022: -$5.78 million | Q1 2023: -$5.61 million | Q2 2023: -$1.24 million | Q3 2023: -$4.64 million | Q1 2024: -$6.62 million | Q2 2024: -$5.55 million | Q3 2024: -$3.64 million | Q1 2025: -$3.05 million | Q2 2025: -$2.57 million | Q3 2025: -$832.0 thousand.
- Over the full 17 years of available data (2009 to 2025), Apyx Medical Corp's Operating Income Loss has declined by 1,001.5%.
- Historical annual values: Fiscal year 2025: -$6.45 million | Fiscal year 2024: -$18.85 million | Fiscal year 2023: -$17.26 million | Fiscal year 2022: -$23.56 million | Fiscal year 2021: -$14.45 million | Fiscal year 2020: -$20.08 million | Fiscal year 2019: -$20.87 million | Fiscal year 2018: -$14.28 million | Fiscal year 2017: -$13.89 million | Fiscal year 2016: -$11.39 million | Fiscal year 2015: -$6.99 million | Fiscal year 2014: -$5.85 million | Fiscal year 2013: -$3.67 million | Fiscal year 2012: $1.05 million | Fiscal year 2011: -$18.0 thousand | Fiscal year 2010: -$2.75 million | Fiscal year 2009: $715.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: